MedPath

jCyte, Inc.

jCyte, Inc. logo
🇺🇸United States
Ownership
Private
Established
2012-01-10
Employees
11
Market Cap
-
Website
http://www.jcyte.com

Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Phase 2
Recruiting
Conditions
Retinitis Pigmentosa
Interventions
Biological: human retinal progenitor cells
Other: Mock injection
First Posted Date
2025-04-06
Last Posted Date
2025-04-24
Lead Sponsor
jCyte, Inc
Target Recruit Count
60
Registration Number
NCT06912633
Locations
🇺🇸

Shiley Eye Institute, UC San Diego, San Diego, California, United States

🇺🇸

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States

🇺🇸

Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

Phase 2
Completed
Conditions
Retinitis Pigmentosa
Interventions
Biological: human retinal progenitor cells
First Posted Date
2020-10-27
Last Posted Date
2024-07-16
Lead Sponsor
jCyte, Inc
Target Recruit Count
30
Registration Number
NCT04604899
Locations
🇺🇸

Gavin Herbert Eye Inst, Univ Cal Irvine, Irvine, California, United States

🇺🇸

Retina-Vitreous Associates Medical Group, Los Angeles, California, United States

🇺🇸

Ophthalmic Consultants of Boston, Boston, Massachusetts, United States

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Phase 2
Completed
Conditions
Retinitis Pigmentosa
Interventions
Biological: human retinal progenitor cells
Other: Mock injection
First Posted Date
2017-03-08
Last Posted Date
2024-06-18
Lead Sponsor
jCyte, Inc
Target Recruit Count
84
Registration Number
NCT03073733
Locations
🇺🇸

Gavin Herbert Eye Inst, Univ Cal Irvine, Irvine, California, United States

🇺🇸

Retina-Vitreous Associates Medical Group, Los Angeles, California, United States

🇺🇸

Ophthalmic Consultants of Boston, Boston, Massachusetts, United States

Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa

Phase 1
Completed
Conditions
Retinitis Pigmentosa (RP)
Interventions
Biological: human retinal progenitor cells
First Posted Date
2014-12-19
Last Posted Date
2019-03-05
Lead Sponsor
jCyte, Inc
Target Recruit Count
28
Registration Number
NCT02320812
Locations
🇺🇸

The Gavin Herbert Eye Institute, Univ California Irvine, Irvine, California, United States

🇺🇸

Retina-Vitreous Associates Medical Group, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath